Risankizumab Maintenance Therapy Results in Sustained Improvements in Endoscopic Outcomes in Patients with Moderate to Severe Crohn's Disease: Post-Hoc Analysis from the Phase 3 Study Fortify
AuthID
P-00W-HP3
P-00W-HP3